Search

Sahm Nasseri

Sahm Nasseri is a director in global strategy and marketing of HPV Vaccines at Merck & Co, based in New York USA. He started at Merck in the Australian subsidiary where he was strategy and business development lead, reporting to the managing director and is part of the local country leadership team. Prior to joining Merck, Mr Nasseri was a management consultant with McKinsey & Company based in the Sydney office. During his 4 years at McKinsey, Mr Nasseri was involved in leading strategy and operations programs across several clients in healthcare, pharma, telecommunications, retail and mining. He has broad strategy, marketing, commercial deal-making and policy experience in the healthcare space across Asia Pacific and the US. Mr Nasseri holds an MBA through a combined program at Columbia University in New York and the London Business School, and has a Bachelors in Chemical Engineering (Hons) from the University of New South Wales.
Bio last updated 28 Oct 2017

Access to our data for Sahm Nasseri is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Sahm Nasseri is linked to 2 organisations which are included in 1 list - Public Companies - Industrial.

To see the data you will need to .

Total Shareholder Return as at 31/10/18

1 year TSR5 year TSR
129thEve Investments40%1%
152ndAusCann Group Holdings33%50%
417thPhylogica-11%13%
621stPLC Financial Solutions-42%-41%
744 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Roles

2017
Non-Executive Director
Year started and most recent title

Share Transactions

18/01/18
$9k Issued
18/01/18
$0 Issued
31/08/17
$5k Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

211th↓AusCann Group Holdings$54k
212th↓Activistic$49k
213th↓Phylogica$48k
214th-PLC Financial Solutions$20k
215th↓Eve Investments$19k
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer